Guangzhou RiboBio Co., Ltd (RiboBio) is a leading biotechnology company in China that focuses on providing ribonucleic acid (RNA) based products and services with a world-class R&D team and cutting-edge technologies at the most advanced facilities. According to the 2017 Frost & Sullivan Report, RiboBio was ranked No. 1 in terms of revenue among other companies that offer RNA-based products and services in China. Our RNA-based products and services primarily include reagents, contract research organization (CRO) services, contract development, and manufacturing organization (CDMO) services. RiboBio is dedicated to providing diversified and high-quality reagents, such as siRNA, microRNA (miRNA) mimics (agomir) and inhibitors (antagomir), LncRNA probe, and smart silencing kit used for RNA-related research. In particular, we have over 15 years of experience in synthesizing and manufacturing oligonucleotides of various configurations and chemistry, where we produced and commercialized over 1,000,000 oligonucleotides. RiboBio provides a unique “one-stop” RNA-based outsourcing services that meet our customers’ needs at various stages of the entire chain of drug discovery, development, and manufacturing. Our CRO services range from RNA-based drug design and screening, lead molecule validation and optimization, to efficacy and toxicity studies at the pre-clinical stage. Our CDMO services primarily consist of the comprehensive chemistry, manufacturing, and control (CMC) services regarding the process development, analytical method development and validation, stability studies, and GMP validation for oligo-based active pharmaceutical ingredients (APIs), as well as manufacturing services of both GMP and non-GMP oligo-based APIs. Our broad and integrated RNA-based outsourcing services allow us to address a variety of needs of scientists and researchers from colleges and universities, pharmaceutical and biotech companies, research institutions, and hospitals.